Free Trial
NASDAQ:UPB

Upstream Bio (UPB) Stock Price, News & Analysis

Upstream Bio logo
$10.88 +0.17 (+1.54%)
As of 10:43 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About Upstream Bio Stock (NASDAQ:UPB)

Key Stats

Today's Range
$10.73
$11.08
50-Day Range
$8.56
$11.84
52-Week Range
$5.14
$29.46
Volume
25,400 shs
Average Volume
349,612 shs
Market Capitalization
$585.50 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$56.50
Consensus Rating
Buy

Company Overview

Receive UPB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Upstream Bio and its competitors with MarketBeat's FREE daily newsletter.

UPB Stock News Headlines

Upstream Bio begins phase 2 COPD trial for verekitug
Trump's 2025 Economic Revolution Is Here Are Your Retirement Savings Ready?
Time is short. Trump's reforms may be coming fast—and the financial system roller coaster may be a ride that you don't want to take with your retirement savings.
UPB Upstream Bio, Inc. - Seeking Alpha
See More Headlines

UPB Stock Analysis - Frequently Asked Questions

Upstream Bio's stock was trading at $16.44 at the beginning of 2025. Since then, UPB stock has decreased by 33.8% and is now trading at $10.8850.

Upstream Bio, Inc. (NASDAQ:UPB) issued its earnings results on Tuesday, May, 6th. The company reported ($0.51) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.49) by $0.02. The business earned $0.57 million during the quarter, compared to analysts' expectations of $0.71 million.

Upstream Bio (UPB) raised $200 million in an IPO on Friday, October 11th 2024. The company issued 12,500,000 shares at $15.00-$17.00 per share. JPMorgan, TD Cowen, Piper Sandler and William Blair served as the underwriters for the IPO.

Shares of UPB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Last Earnings
5/06/2025
Today
7/21/2025
Next Earnings (Estimated)
8/05/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:UPB
Previous Symbol
NASDAQ:UPB
CIK
2022626
Fax
N/A
Employees
38
Year Founded
N/A

Price Target and Rating

High Price Target
$75.00
Low Price Target
$38.00
Potential Upside/Downside
+427.1%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
4 Analysts

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
47.43
Quick Ratio
47.43

Sales & Book Value

Annual Sales
$2.37 million
Price / Sales
243.30
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$8.77 per share
Price / Book
1.22

Miscellaneous

Outstanding Shares
53,790,000
Free Float
46,500,000
Market Cap
$576.63 million
Optionable
N/A
Beta
N/A
10 Stocks Set to Soar in Summer 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

This page (NASDAQ:UPB) was last updated on 7/21/2025 by MarketBeat.com Staff
From Our Partners